Cargando…
BMP9‐induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus‐associated hepatocellular carcinoma
BACKGROUND: In the past decade, the field of tumour immunotherapy has made a great progress. However, the efficacy of immune checkpoint blocking (ICB) in the treatment of hepatocellular carcinoma (HCC) remains limited. Cytotoxic lymphocyte trafficking into tumours is critical for the success of ICB....
Autores principales: | Han, Yulong, Pan, Qiuzhong, Guo, Zhixing, Du, Yufei, Zhang, Yaojun, Liu, Yingying, Zhao, Jingjing, Xu, Jinfeng, Yang, Jieying, Ouyang, Dijun, Tang, Yan, Wang, Qijing, Li, Yongqiang, He, Jia, Yang, Mengjuan, Chen, Hao, Yang, Chaopin, Yang, Xinyi, You, Jinqi, Chen, Yuanyuan, Ren, Minghao, Zhu, Yao, Xia, Jianchuan, Xiang, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154878/ https://www.ncbi.nlm.nih.gov/pubmed/37132170 http://dx.doi.org/10.1002/ctm2.1247 |
Ejemplares similares
-
Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinoma
por: Yang, Chaopin, et al.
Publicado: (2023) -
Lenvatinib improves anti-PD-1 therapeutic efficacy by promoting vascular normalization via the NRP-1-PDGFRβ complex in hepatocellular carcinoma
por: Yang, Jieying, et al.
Publicado: (2023) -
SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway
por: Yang, Jieying, et al.
Publicado: (2022) -
Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin
por: Sun, Fengze, et al.
Publicado: (2021) -
CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma
por: Huang, Yue, et al.
Publicado: (2022)